Table 4 Comparison of pathological and follow-up outcomes between SILS and CLS for the included studies
Study | Lymph node resection (n) | Proximal surgical edge (cm) | Distal surgical edge (cm) | Recurrence | Metastasis | |||||
|---|---|---|---|---|---|---|---|---|---|---|
SILS | CLS | SILS | CLS | SILS | CLS | SILS | CLS | SILS | CLS | |
Curro [9] | 25 | 24 | NR | NR | 15.5 | 13 | NR | NR | NR | NR |
Yun [10] | 24 ± 11 | 27 ± 13 | 14.4 ± 8.4 | 15 ± 7.8 | 16.6 ± 6.2 | 15.8 ± 7.6 | 6 | 3 | NR | NR |
Takemasa [11] | 23.9 ± 6.7 | 23.7 ± 7.4 | NR | NR | NR | NR | NR | NR | NR | NR |
Suzuki [12] | 16 | 15 | NR | NR | NR | NR | NR | NR | 1 | 2 |
Yu [13] | 28.0 ± 16.3 | 28.7 ± 12.2 | NR | NR | NR | NR | NR | NR | 1 | 7 |
Tokudka [14] | 24.3 ± 9.2 | 24.2 ± 16.9 | 12.8 ± 6.8 | 12.5 ± 7.9 | 9.1 ± 6.9 | 8.4 ± 4.2 | NR | NR | NR | NR |
Chouillard [15] | 16.5 ± 6.3 | 17.7 ± 5.2 | 6.9 ± 4.9 | 7.2 ± 4.5 | 6.7 ± 3.0 | 7.3 ± 2.4 | NR | NR | NR | NR |
Kim [16] | 28.3 ± 13.5 | 25.6 ± 11.3 | 17.3 ± 9.2 | 18.3 ± 11.6 | 17.9 ± 8.9 | 17.7 ± 8.2 | 0 | 2 | 1 | 1 |
Song [17] | 17 | 17 | 8.75 | 12 | 10.5 | 12 | 0 | 1 | 3 | 2 |